文献速递创伤与烧伤复苏、休克与脓毒症

创伤院前止血敷料:系统综述

Prehospital haemostatic dressings for trauma: a systematic review.
PubMed 文献 · Emerg Med J · 2018-05-04
一句话结论止血敷料用于院前创伤性出血有效,QuikClot Combat Gauze因临床数据量和安全性可能被论证为最优选择,但缺乏高质量证据。

该系统综述检索MEDLINE和EMBASE,纳入17项研究共809例患者(469例军事、340例民用),其中15项观察性研究、1项病例报告和1项随机对照试验。止血停止范围为67%至100%,中位数90.5%。QuikClot Combat Gauze应用最多(420次),三项研究未报告不良事件;仅QuikClot颗粒剂报告烧伤不良事件。所有研究存在偏倚风险,质量评估为极低至中等。作者认为止血敷料对创伤性出血提供有效院前治疗,QuikClot Combat Gauze可能被论证为最优选择,但缺乏高质量临床证据,需要随机对照试验。

要点

  • 17项研究共809例患者(469例军事、340例民用),止血停止范围67%至100%,中位数90.5%。
  • QuikClot Combat Gauze应用最多(420次),三项研究未报告不良事件;仅QuikClot颗粒剂报告烧伤。
  • 所有研究存在偏倚风险,质量评估为极低至中等;7项研究未报告安全性数据。
  • 作者认为QuikClot Combat Gauze可能因临床数据量和安全性被论证为最优选择,但缺乏高质量证据。

适用人群与场景

  • 院前创伤性出血患者,包括军事和民用场景,共809例(469例军事、340例民用)。

研究设计与关键结果

  • 系统综述纳入17项研究(15项观察性研究、1项病例报告、1项随机对照试验),共809例患者(469例军事、340例民用)。
  • 止血停止范围为67%至100%,中位数90.5%。
  • 报告了7种不同止血敷料,QuikClot Combat Gauze应用最多(420次)。
  • 仅QuikClot颗粒剂报告不良事件(烧伤);三项研究使用QuikClot Combat Gauze未报告不良事件;7项研究未报告安全性数据。
  • 所有研究存在偏倚风险,质量评估为极低至中等。

证据类型、等级与局限

  • 证据类型:系统综述,证据等级为IV级。
  • 因研究和临床异质性无法进行Meta分析。
  • 所有研究存在偏倚风险,质量评估为极低至中等;7项研究未报告安全性数据。
  • 作者结论:止血敷料对创伤性出血提供有效院前治疗;QuikClot Combat Gauze可能因临床数据量和安全性被论证为最优选择,但缺乏高质量临床证据,需要随机对照试验。

对床旁实践的改变

  • 作者认为止血敷料对创伤性出血提供有效院前治疗。
  • 作者认为QuikClot Combat Gauze可能因临床数据量和安全性被论证为最优选择。
  • 作者指出缺乏高质量临床证据,需要随机对照试验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Haemorrhage is a major cause of mortality and morbidity following both military and civilian trauma. Haemostatic dressings may offer effective haemorrhage control as part of prehospital treatment.

AIM: To conduct a systematic review of the clinical literature to assess the prehospital use of haemostatic dressings in controlling traumatic haemorrhage, and determine whether any haemostatic dressings are clinically superior.

METHODS: MEDLINE and EMBASE databases were searched using predetermined criteria. The reference lists of all returned review articles were screened for eligible studies. Two authors independently undertook the search, performed data extraction, and risk of bias and Grading of Recommendations, Assessment, Development and Evaluation quality assessments. Meta-analysis could not be undertaken due to study and clinical heterogeneity.

RESULTS: Our search yielded 470 studies, of which 17 met eligibility criteria, and included 809 patients (469 military and 340 civilian). There were 15 observational studies, 1 case report and 1 randomised controlled trial. Indications for prehospital haemostatic dressing use, wound location, mechanism of injury, and source of bleeding were variable. Seven different haemostatic dressings were reported with QuikClot Combat Gauze being the most frequently applied (420 applications). Cessation of bleeding ranged from 67% to 100%, with a median of 90.5%. Adverse events were only reported with QuikClot granules, resulting in burns. No adverse events were reported with QuikClot Combat Gauze use in three studies. Seven of the 17 studies did not report safety data. All studies were at risk of bias and assessed of 'very low' to 'moderate' quality.

CONCLUSIONS: Haemostatic dressings offer effective prehospital treatment for traumatic haemorrhage. QuikClot Combat Gauze may be justified as the optimal agent due to the volume of clinical data and its safety profile, but there is a lack of high-quality clinical evidence, and randomised controlled trials are warranted.

LEVEL OF EVIDENCE: Systematic review, level IV.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Boulton AJ, Lewis CT, Naumann DN, et al. Prehospital haemostatic dressings for trauma: a systematic review. Emerg Med J. 2018. PMID: 29728411. doi:10.1136/emermed-2018-207523

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。